Nifty
:
25482.50
Sensex
:
82276.07
57.85 (0.23%)
50.15 (0.06%)
Nifty
Sensex
:
:
25482.50
82276.07
57.85 (0.23%)
50.15 (0.06%)

Mankind Pharma Ltd.

Pharmaceuticals & Drugs

Rating :
61/99

BSE: 543904 | NSE: MANKIND

NSE BSE
2054.70
24-Feb-2026
  • Open
  • High
  • Low
  • Previous Close
  •  2037
  •  2060.6
  •  2029.4
  •  2046.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  217522
  •  445774772.5
  •  2716.5
  •  2012.3

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 84,767.46
  • 47.64
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 92,513.11
  • N/A
  • 5.40

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.66%
  • 1.08%
  • 1.52%
  • FII
  • DII
  • Others
  • 11.34%
  • 10.42%
  • 2.98%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.96
  • 14.46
  • 11.74

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.81
  • 12.87
  • 9.69

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.91
  • 9.44
  • 15.72

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 51.74

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 9.87

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 32.05

Earnings Forecasts:

(Updated: 21-02-2026)
Description
2024
2025
2026
2027
Adj EPS
48.26
46.94
59.01
71.82
P/E Ratio
42.58
43.77
34.82
28.61
Revenue
12207.4
14279.8
15917.4
17733.4
EBITDA
3554.72
3519.64
4051.26
4625.08
Net Income
1990.96
1931.37
2431.57
2960.37
ROA
10.02
7.04
8.6
10.18
P/B Ratio
5.91
5.23
4.59
4.00
ROE
16.8
12.49
13.92
14.69
FCFF
1913.15
2149.76
2448.45
2865.74
FCFF Yield
2.09
2.35
2.67
3.13
Net Debt
6266.11
4150.42
1478.19
-1403.49
BVPS
347.39
393.08
447.87
513.67

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
3,567.20
3,198.79
11.52%
3,697.16
3,061.43
20.77%
3,570.35
2,867.85
24.50%
3,079.37
2,422.24
27.13%
Expenses
2,647.77
2,382.80
11.12%
2,775.83
2,214.24
25.36%
2,723.58
2,196.29
24.01%
2,396.18
1,835.94
30.52%
EBITDA
919.43
815.99
12.68%
921.33
847.19
8.75%
846.77
671.56
26.09%
683.19
586.30
16.53%
EBIDTM
25.77%
25.51%
24.92%
27.67%
23.72%
23.42%
22.19%
24.20%
Other Income
72.75
77.00
-5.52%
91.87
109.06
-15.76%
79.88
99.40
-19.64%
251.33
92.15
172.74%
Interest
157.20
220.93
-28.85%
169.68
7.10
2,289.86%
170.65
10.84
1,474.26%
190.54
9.17
1,977.86%
Depreciation
222.60
187.17
18.93%
221.82
100.49
120.74%
218.68
102.69
112.95%
230.87
99.78
131.38%
PBT
505.79
484.89
4.31%
621.70
848.66
-26.74%
537.32
657.43
-18.27%
513.11
569.50
-9.90%
Tax
95.12
110.46
-13.89%
103.84
189.98
-45.34%
95.87
122.86
-21.97%
86.44
94.99
-9.00%
PAT
410.67
374.43
9.68%
517.86
658.68
-21.38%
441.45
534.57
-17.42%
426.67
474.51
-10.08%
PATM
11.51%
11.71%
14.01%
21.52%
12.36%
18.64%
13.86%
19.59%
EPS
9.90
9.22
7.38%
12.39
16.31
-24.03%
10.62
13.39
-20.69%
10.20
11.76
-13.27%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
13,914.08
12,207.44
10,260.44
8,749.43
7,781.56
6,214.43
5,871.87
4,979.98
4,920.74
4,382.26
3,943.66
Net Sales Growth
20.46%
18.98%
17.27%
12.44%
25.22%
5.83%
17.91%
1.20%
12.29%
11.12%
 
Cost Of Goods Sold
3,969.13
3,489.04
3,198.47
2,913.64
2,421.73
1,780.60
1,878.07
1,721.34
1,670.59
1,585.80
1,550.56
Gross Profit
9,944.95
8,718.40
7,061.97
5,835.79
5,359.83
4,433.82
3,993.80
3,258.64
3,250.16
2,796.46
2,393.10
GP Margin
71.47%
71.42%
68.83%
66.70%
68.88%
71.35%
68.02%
65.43%
66.05%
63.81%
60.68%
Total Expenditure
10,543.36
9,186.97
7,745.27
6,847.50
5,791.01
4,565.32
4,427.16
4,054.95
3,927.09
3,531.31
3,184.58
Power & Fuel Cost
-
149.49
125.16
108.96
103.13
82.53
79.96
64.15
41.71
24.57
15.42
% Of Sales
-
1.22%
1.22%
1.25%
1.33%
1.33%
1.36%
1.29%
0.85%
0.56%
0.39%
Employee Cost
-
2,692.37
2,260.60
1,918.47
1,620.59
1,415.78
1,335.53
1,094.79
1,076.75
883.58
736.79
% Of Sales
-
22.06%
22.03%
21.93%
20.83%
22.78%
22.74%
21.98%
21.88%
20.16%
18.68%
Manufacturing Exp.
-
216.03
172.71
150.57
160.29
140.14
109.22
85.46
104.83
72.85
42.50
% Of Sales
-
1.77%
1.68%
1.72%
2.06%
2.26%
1.86%
1.72%
2.13%
1.66%
1.08%
General & Admin Exp.
-
1,314.02
939.49
1,000.80
655.99
451.75
439.00
508.16
424.35
362.38
317.44
% Of Sales
-
10.76%
9.16%
11.44%
8.43%
7.27%
7.48%
10.20%
8.62%
8.27%
8.05%
Selling & Distn. Exp.
-
1,164.71
924.26
638.11
708.17
587.73
426.72
521.81
541.84
557.66
500.10
% Of Sales
-
9.54%
9.01%
7.29%
9.10%
9.46%
7.27%
10.48%
11.01%
12.73%
12.68%
Miscellaneous Exp.
-
161.31
124.58
116.96
121.10
106.78
158.66
59.24
67.04
44.47
500.10
% Of Sales
-
1.32%
1.21%
1.34%
1.56%
1.72%
2.70%
1.19%
1.36%
1.01%
0.55%
EBITDA
3,370.72
3,020.47
2,515.17
1,901.93
1,990.55
1,649.11
1,444.71
925.03
993.65
850.95
759.08
EBITDA Margin
24.23%
24.74%
24.51%
21.74%
25.58%
26.54%
24.60%
18.57%
20.19%
19.42%
19.25%
Other Income
495.83
536.79
280.22
128.57
196.03
170.95
103.78
52.92
72.06
89.08
71.00
Interest
688.07
431.95
34.24
45.76
59.80
21.16
23.24
44.24
25.22
3.64
2.71
Depreciation
893.97
621.22
378.42
325.92
166.62
118.97
99.06
69.03
45.83
30.79
43.41
PBT
2,177.92
2,504.09
2,382.73
1,658.81
1,960.15
1,679.93
1,426.20
864.66
994.67
905.60
783.96
Tax
381.27
509.74
457.15
361.56
521.64
398.58
381.59
264.12
322.87
289.69
243.74
Tax Rate
17.51%
20.36%
19.19%
21.80%
26.61%
23.73%
26.76%
30.55%
32.46%
31.99%
31.09%
PAT
1,796.65
1,986.43
1,911.92
1,281.86
1,433.48
1,265.42
1,030.42
578.53
643.72
615.91
540.22
PAT before Minority Interest
1,772.67
2,006.59
1,940.79
1,309.68
1,452.96
1,293.03
1,056.14
610.48
671.80
615.91
540.22
Minority Interest
-23.98
-20.16
-28.87
-27.82
-19.48
-27.61
-25.72
-31.95
-28.08
0.00
0.00
PAT Margin
12.91%
16.27%
18.63%
14.65%
18.42%
20.36%
17.55%
11.62%
13.08%
14.05%
13.70%
PAT Growth
-12.02%
3.90%
49.15%
-10.58%
13.28%
22.81%
78.11%
-10.13%
4.52%
14.01%
 
EPS
43.52
48.12
46.32
31.05
34.73
30.65
24.96
14.01
15.59
14.92
13.09

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
14,332.39
9,363.09
7,435.22
6,155.23
4,722.00
3,485.31
2,823.05
2,880.91
2,927.14
2,256.95
Share Capital
41.26
40.06
40.06
40.06
40.06
40.06
40.06
40.06
20.03
20.03
Total Reserves
14,247.46
9,299.78
7,395.10
6,115.17
4,681.94
3,445.25
2,782.99
2,840.85
2,907.11
2,236.93
Non-Current Liabilities
7,419.90
187.34
199.24
168.68
107.33
103.04
77.79
49.19
53.24
34.37
Secured Loans
5,077.83
24.87
23.15
48.94
57.42
58.19
25.11
2.70
1.43
0.10
Unsecured Loans
448.36
0.00
0.00
0.25
0.25
0.00
0.00
0.34
1.25
2.29
Long Term Provisions
155.06
123.12
97.89
80.00
72.24
63.00
44.92
35.63
25.04
17.86
Current Liabilities
5,663.56
2,119.73
1,863.14
2,623.46
1,353.40
1,250.73
1,024.06
1,296.24
662.57
527.51
Trade Payables
1,133.40
777.06
1,008.18
1,076.40
666.97
745.11
561.97
649.14
491.82
419.10
Other Current Liabilities
1,335.07
755.50
386.05
472.89
282.77
180.05
116.53
161.51
140.02
100.64
Short Term Borrowings
2,513.14
151.48
115.02
794.59
158.35
44.28
241.46
404.15
9.94
0.00
Short Term Provisions
681.95
435.69
353.89
279.59
245.30
281.29
104.10
81.44
20.80
7.76
Total Liabilities
27,651.64
11,882.86
9,685.67
9,108.45
6,323.62
5,025.34
4,083.52
4,360.47
3,741.01
2,848.31
Net Block
19,004.48
4,539.95
4,245.28
3,582.77
1,658.94
1,594.04
1,399.46
1,013.77
793.31
446.98
Gross Block
20,916.96
5,909.74
5,233.03
4,246.54
2,160.04
1,987.79
1,681.37
1,229.77
915.35
488.62
Accumulated Depreciation
1,912.48
1,369.79
987.75
663.78
501.10
372.99
281.91
216.00
122.04
41.64
Non Current Assets
20,663.37
5,314.64
5,357.80
4,701.63
2,416.98
2,203.13
2,085.41
1,786.75
1,672.00
1,141.79
Capital Work in Progress
825.67
281.80
550.15
701.47
371.95
316.95
327.87
525.07
301.66
139.15
Non Current Investment
351.09
309.81
270.95
235.01
205.80
164.39
215.66
139.38
100.98
53.80
Long Term Loans & Adv.
293.08
163.97
187.54
163.88
158.07
106.06
117.69
77.10
259.59
335.97
Other Non Current Assets
189.00
13.79
98.51
13.09
16.72
16.12
14.35
8.52
9.07
6.55
Current Assets
6,985.57
6,565.52
4,324.56
4,403.84
3,879.62
2,819.50
1,943.15
2,573.71
2,069.01
1,706.53
Current Investments
1,690.84
2,258.11
1,075.47
874.46
1,306.17
665.03
543.27
649.87
847.94
655.02
Inventories
2,093.71
1,553.46
1,498.46
1,760.24
1,183.54
899.13
820.99
789.25
788.87
619.11
Sundry Debtors
1,538.34
848.28
576.42
388.17
330.61
531.09
220.22
296.67
166.46
192.71
Cash & Bank
554.50
708.10
453.20
405.94
700.74
419.88
141.01
138.95
145.87
89.58
Other Current Assets
1,108.18
104.10
64.29
170.74
358.56
304.37
217.67
698.97
119.88
150.12
Short Term Loans & Adv.
1,010.76
1,093.47
656.71
804.29
275.79
294.21
209.18
230.00
88.91
64.48
Net Current Assets
1,322.01
4,445.79
2,461.42
1,780.37
2,526.22
1,568.77
919.09
1,277.48
1,406.44
1,179.01
Total Assets
27,648.94
11,880.16
9,682.36
9,105.47
6,296.60
5,022.63
4,028.56
4,360.46
3,741.01
2,848.32

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
2,413.38
2,152.44
1,813.30
919.78
1,137.24
PBT
2,524.78
2,399.35
1,671.24
1,974.60
1,691.61
Adjustment
601.77
212.19
298.43
30.81
-5.66
Changes in Working Capital
-146.42
-17.57
166.73
-586.12
-94.63
Cash after chg. in Working capital
2,980.13
2,593.97
2,136.40
1,419.29
1,591.32
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-566.75
-441.53
-323.10
-499.51
-454.07
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-12,682.95
-2,081.69
-1,054.13
-1,369.14
-1,222.21
Net Fixed Assets
-270.57
-517.31
-591.49
-2,286.21
Net Investments
-12,468.02
-1,113.13
-576.36
-128.98
Others
55.64
-451.25
113.72
1,046.05
Cash from Financing Activity
10,232.56
5.27
-739.73
604.62
-7.81
Net Cash Inflow / Outflow
-37.01
76.02
19.44
155.26
-92.78
Opening Cash & Equivalents
382.01
304.82
283.06
127.33
219.73
Closing Cash & Equivalent
403.88
382.01
304.82
283.06
127.33

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
346.31
233.15
185.61
153.65
117.88
ROA
10.15%
18.00%
13.94%
18.83%
22.79%
ROE
16.98%
23.14%
19.27%
26.72%
31.51%
ROCE
18.32%
28.35%
23.49%
33.96%
39.97%
Fixed Asset Turnover
0.95
1.92
1.92
2.52
3.00
Receivable days
34.35
24.35
19.33
16.25
25.31
Inventory Days
52.50
52.16
65.31
66.57
61.16
Payable days
99.93
101.86
130.57
131.38
144.73
Cash Conversion Cycle
-13.08
-25.35
-45.92
-48.56
-58.26
Total Debt/Equity
0.58
0.02
0.02
0.14
0.05
Interest Cover
6.83
71.03
37.52
34.02
80.96

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Mankind Pharma - Quarterly Results
    4th Feb 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.